HealthEquity Files 8-K for Financial Updates
Ticker: HQY · Form: 8-K · Filed: Mar 19, 2024 · CIK: 1428336
| Field | Detail |
|---|---|
| Company | Healthequity, INC. (HQY) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, company-update
Related Tickers: HQY
TL;DR
HealthEquity dropped an 8-K with financial updates - check it out.
AI Summary
HealthEquity, Inc. filed an 8-K on March 19, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing provides updated information regarding the company's financial performance and related disclosures.
Why It Matters
This filing provides crucial financial information and updates for investors and stakeholders of HealthEquity, Inc., impacting their understanding of the company's current operational and financial standing.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- HEALTHEQUITY, INC. (company) — Filer
- March 19, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing by HealthEquity, Inc.?
The primary purpose of this 8-K filing is to report on HealthEquity, Inc.'s results of operations and financial condition, and to file financial statements and exhibits.
On what date was this 8-K filing submitted?
This 8-K filing was submitted on March 19, 2024.
What is HealthEquity, Inc.'s principal executive office address?
HealthEquity, Inc.'s principal executive offices are located at 15 West Scenic Pointe Drive, Suite 100, Draper, Utah 84020.
What is the telephone number for HealthEquity, Inc.'s principal executive offices?
The telephone number for HealthEquity, Inc.'s principal executive offices is (801) 727-1000.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
Filing Stats: 494 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-03-19 16:03:10
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share HQY The NASDAQ Global Select
Filing Documents
- hqy-20240319.htm (8-K) — 24KB
- hqyq4fy24earningsrelease.htm (EX-99.1) — 332KB
- 0001428336-24-000009.txt ( ) — 505KB
- hqy-20240319.xsd (EX-101.SCH) — 2KB
- hqy-20240319_lab.xml (EX-101.LAB) — 22KB
- hqy-20240319_pre.xml (EX-101.PRE) — 13KB
- hqy-20240319_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On March 19, 2024, HealthEquity, Inc. issued a press release attached as Exhibit 99.1 to this current report on Form 8-K. The information in Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press release issued by HealthEquity, Inc. dated March 19, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHEQUITY, INC. Date: March 19, 2024 By: /s/ James Lucania Name: James Lucania Title: Executive Vice President and Chief Financial Officer